The aim of this commentary is to examine the benefits of oral formulations of fentanyl products and it's use with break through cancer pain. It compares the use of oral, buccal, sublingual and soluble fentanyl products, their administration, tolerability and cost benefit.
Handsaker, S., Dempsey, L. & Fabby, C. 2015. Use of oral formulations of fentanyl for breakthrough cancer pain. International Journal of Palliative Nursing, 21 (6) p 168 - 172.
You can request this article from the library or download yourself using your Athens username and password. To request a copy from the library click here fill in form and return to the library.